| abstract |
The present invention relates to a method for diagnosing a disease or for evaluating the risk to develop a disease which is characterized by dyslipidemia in humans, in particular for diagnosing atherosclerosis, coronary heart disease (CHD), peripheral vascular disease (PVD), stroke, the metabolic syndrome, diabetes (type I and II) and diabetes related sequale (like diabetic polyneuropathy, diabetic retinopathie or diabetic nephropathie) as well as lipid associated neuropathies (like Charcot-Marie-Tooth neuropathies such as hereditary sensory and autonomous neuropathy type 1 (HSAN1)). |